chr20-41084548-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_003286.4(TOP1):āc.594A>Gā(p.Glu198Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0023 in 1,570,354 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.0016 ( 0 hom., cov: 32)
Exomes š: 0.0024 ( 6 hom. )
Consequence
TOP1
NM_003286.4 synonymous
NM_003286.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.09
Genes affected
TOP1 (HGNC:11986): (DNA topoisomerase I) This gene encodes a DNA topoisomerase, an enzyme that controls and alters the topologic states of DNA during transcription. This enzyme catalyzes the transient breaking and rejoining of a single strand of DNA which allows the strands to pass through one another, thus altering the topology of DNA. This gene is localized to chromosome 20 and has pseudogenes which reside on chromosomes 1 and 22. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 20-41084548-A-G is Benign according to our data. Variant chr20-41084548-A-G is described in ClinVar as [Benign]. Clinvar id is 713745.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=2.09 with no splicing effect.
BS2
High AC in GnomAd4 at 248 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TOP1 | NM_003286.4 | c.594A>G | p.Glu198Glu | synonymous_variant | 8/21 | ENST00000361337.3 | NP_003277.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TOP1 | ENST00000361337.3 | c.594A>G | p.Glu198Glu | synonymous_variant | 8/21 | 1 | NM_003286.4 | ENSP00000354522.2 | ||
TOP1 | ENST00000681058.1 | n.748A>G | non_coding_transcript_exon_variant | 8/20 | ||||||
TOP1 | ENST00000681113.1 | n.594A>G | non_coding_transcript_exon_variant | 8/23 | ENSP00000505788.1 | |||||
TOP1 | ENST00000681392.1 | n.1714A>G | non_coding_transcript_exon_variant | 4/18 |
Frequencies
GnomAD3 genomes AF: 0.00162 AC: 247AN: 152252Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
247
AN:
152252
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00174 AC: 334AN: 191736Hom.: 2 AF XY: 0.00172 AC XY: 175AN XY: 102026
GnomAD3 exomes
AF:
AC:
334
AN:
191736
Hom.:
AF XY:
AC XY:
175
AN XY:
102026
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00237 AC: 3362AN: 1417984Hom.: 6 Cov.: 29 AF XY: 0.00221 AC XY: 1552AN XY: 701806
GnomAD4 exome
AF:
AC:
3362
AN:
1417984
Hom.:
Cov.:
29
AF XY:
AC XY:
1552
AN XY:
701806
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00163 AC: 248AN: 152370Hom.: 0 Cov.: 32 AF XY: 0.00150 AC XY: 112AN XY: 74520
GnomAD4 genome
AF:
AC:
248
AN:
152370
Hom.:
Cov.:
32
AF XY:
AC XY:
112
AN XY:
74520
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
TOP1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 21, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at